Search
for
Sort by
Research 61–90 of 272
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Dermatologie care behind bars
- Thrombocytosis Associated with Low-Molecular-Weight Heparin
- Adult Group B Streptococcal Disease
- Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort
- Male Pattern Baldness
- Effects of dobutamine on cyclic AMP accumulation induced by the stimulation of dopamine receptors in rabbit retina in vitro
- Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cells
- Anticoagulant-free preparation of autologous platelet-rich plasma (PRP) / fluid platelet-rich fibrin (f-PRF): a pre-clinical comparative performance study
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- Gender Differences in Production and Circulating Levels of Sex Hormones and Their Impact on Aging Skin
- Syndromes of Severe Insulin Resistance (SSIRs)
- Quantitation of Hepatitis C Virus RNA
- Diagnosing Vascular Causes of Renal Failure
- Liver Cirrhosis and Circadian Rhythm
- Dermatoses of pregnancy
- Cutaneous complications of chemotherapeutic agents
- GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
- What causes hidradenitis suppurativa ?—15 years after
- Mechanical forces in skin disorders
- TOXIC EPIDERMAL NECROLYSIS
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Mitoxantrone
- Recent positive selection of a human androgen receptor/ectodysplasin A2 receptor haplotype and its relationship to male pattern baldness
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome